ID   HAB-1
AC   CVCL_9V19
DR   Wikidata; Q54872298
RX   PubMed=2223577;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 25-30 hours (PubMed=2223577).
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
RX   PubMed=2223577; DOI=10.1038/bjc.1990.336;
RA   Faller G., Vollmers H.P., Weiglein I., Marx A., Zink C., Pfaff M.,
RA   Muller-Hermelink H.-K.;
RT   "HAB-1, a new heteromyeloma for continuous production of human
RT   monoclonal antibodies.";
RL   Br. J. Cancer 62:595-598(1990).
//